DOE Review 08/24/2016

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

DCAS-RPT-005 Rev 01 

Supersedes: DCAS-RPT-005 Rev 00

Alternative Dissolution Models for Insoluble Pu-238

Dave Allen 

Document Owner, DCAS

Thomas R. LaBone

Elizabeth M. Brackett

Subject Matter Experts, ORAU Team

August 2018

Approval: Signature on file________________

 J.W. Neton, Associate Director for Science

Date: 08/17/2018

National Institute for Occupational Safety and Health (NIOSH) 

Division of Compensation Analysis and Support (DCAS) 

1090 Tusculum Avenue 

Cincinnati, Ohio 45226
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 2 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

PUBLICATION RECORD

EFFECTIVE 

DATE

REVISION 

NUMBER DESCRIPTION

06/30/2016 00 New document initiated to consolidate in one document information 

about insoluble Pu-238 that is relevant to dose reconstruction at 

several sites. 

08/17/2018 01 Revision initiated to remove a typo (SRS) in section A.5.1. Added

text in section A.2 to explain why Mound-13 chosen as 

representative.
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 3 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

TABLE OF CONTENTS

SECTION TITLE PAGE

Acronyms and Abbreviations ............................................................................................................... 5

1.0 Introduction .............................................................................................................................. 6

2.0 Background.............................................................................................................................. 6

3.0 Dissolution Models................................................................................................................... 7

4.0 Attributions and Annotations .................................................................................................. 10

References ........................................................................................................................................ 11

ATTACHMENT A DEVELOPMENT OF DISSOLUTION MODELS .............................................. 13

ATTACHMENT B FITS TO EXCRETION DATA FOR ALL WORKERS ....................................... 31

LIST OF TABLES

TABLE TITLE PAGE

3-1 Parameters of the Alternate Dissolution Model......................................................................... 9

A-1 Summary of dissolution parameters estimated from urinary excretion curves of selected 

LANL, Mound, and SRS workers who had intakes of plutonium-238...................................... 24

A-2 Summary of parameters for alternate and primary dissolution models ................................... 29

A-3 Summary of default dissolution model parameters for the default models .............................. 30
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 4 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

LIST OF FIGURES

FIGURE TITLE PAGE

2-1 Non-monotonic plutonium-238 urinary excretion curve observed in a worker involved in 

the 1971 LANL Wing-9 Event................................................................................................... 7

3-1 Standard form of the ICRP Publication 66 dissolution model.................................................... 8

3-2 Alternate form of the ICRP Publication 66 dissolution model.................................................... 8

3-3 Example of how the parameters for the alternate LANL dissolution model are entered 

into IMBA ...............................................................................................................................10

A-1 Standard dissolution model from ICRP Publication 66 ........................................................... 17

A-2 Observed urinary excretion and fitted curve for LANL-8 ......................................................... 18

A-3 Plots of acute intake urinary excretion curves derived from eleven LANL cases 

compared to the urinary excretion curve for type S Pu-238.................................................... 19

A-4 Observed urinary excretion and fitted curve for Mound-13 ..................................................... 21

A-5 Plots of acute intake urinary excretion curves derived from nine Mound cases compared 

to the urinary excretion curve for type S Pu-238..................................................................... 22

A-6 Observed urinary excretion and fitted curve for SRS-24......................................................... 23

A-7 Plots of acute intake urinary excretion curves derived from LANL, Mound, and SRS 

cases (compared to the urinary excretion curve for types S and M Pu-238)........................... 26

A-8 Observed urinary excretion data with the USTUR fit and the LANL-8 fit................................. 28

A-9 Alternate form of ICRP 66 dissolution model.......................................................................... 28

A-10 Excretion curves for Mound-13, LANL-8, USTUR-23, SRS-24, and standard types M and 

S material...............................................................................................................................30

B-1 Urinary excretion and fitted model for LANL-1 ........................................................................ 32

B-2 Urinary excretion and fitted model for LANL-2 ........................................................................ 33

B-3 Urinary excretion and fitted model for LANL-3 ........................................................................ 34

B-4 Urinary excretion and fitted model for LANL-4 ........................................................................ 35

B-5 Urinary excretion and fitted model for LANL-5 ........................................................................ 36

B-6 Urinary excretion and fitted model for LANL-6 ........................................................................ 37

B-7 Urinary excretion and fitted model for LANL-7 ........................................................................ 38

B-8 Urinary excretion and fitted model for LANL-8 ........................................................................ 39

B-9 Urinary excretion and fitted model for LANL-9 ........................................................................ 40

B-10 Urinary excretion and fitted model for LANL-10...................................................................... 41

B-11 Urinary excretion and fitted model for LANL-11...................................................................... 42

B-12 Urinary excretion and fitted model for Mound-12.................................................................... 43

B-13 Urinary excretion and fitted model for Mound-13.................................................................... 44

B-14 Urinary excretion and fitted model for Mound-14.................................................................... 45

B-15 Urinary excretion and fitted model for Mound-15.................................................................... 46

B-16 Urinary excretion and fitted model for Mound-16.................................................................... 47

B-17 Urinary excretion and fitted model for Mound-17.................................................................... 48

B-18 Urinary excretion and fitted model for Mound-18.................................................................... 49

B-19 Urinary excretion and fitted model for Mound-19.................................................................... 50

B-20 Urinary excretion and fitted model for Mound-20.................................................................... 51

B-21 Urinary excretion and fitted model for SRS-24 ....................................................................... 52
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 5 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ACRONYMS AND ABBREVIATIONS 

Bq becquerel

d day

DCF dose conversion factor

DOE U.S. Department of Energy

dpm disintegrations per minute

g grams

ICRP International Commission on Radiological Protection

IMBA Integrated Modules for Bioassay Analysis

kg kilograms

LANL Los Alamos National Laboratory

m meters 

mrem millirem

NA not applicable

nCi nanocuries

NIOSH National Institute for Occupational Safety and Health

NOCTS NIOSH-Division of Compensation Analysis and Support Claims Tracking System

NUMEC Nuclear Materials & Equipment Corporation

ORAU Oak Ridge Associated Universities

RTG radioisotopic thermoelectric generator

SNAP Systems for Nuclear Auxiliary Power

SRDB Ref ID Site Research Database Reference Identification (number)

SRS Savannah River Site

Sv sievert

TIB technical information bulletin

U.S.C. United States Code

USTUR United States Transuranic and Uranium Registry

W watt

yr year

§ section or sections
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 6 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

1.0 INTRODUCTION

This report provides guidance on the evaluation of intakes for workers who were exposed to insoluble 

forms of 238Pu. To develop this guidance, DOE and atomic weapons employer sites were reviewed to 

determine the likelihood of the potential for exposure to this form of plutonium. This review indicated 

that Los Alamos National Laboratory (LANL), the Mound site, the Savannah River Site (SRS), and the 

Nuclear Materials & Equipment Corporation (NUMEC) are the only sites where significant quantities of 

unencapsulated, insoluble 238Pu would have been present. Positive urine excretion data was located 

for all of these sites, except NUMEC. The available urinary excretion patterns following intakes of 

238Pu at LANL, the Mound site, and the Savannah River Site (SRS) were reviewed. Using these data, 

parameters for site-specific dissolution models were developed for the Mound and LANL sites. As 

discussed in Appendix A, only one of the six available exposure cases at SRS was found to be 

suitable for evaluation, which was judged to be insufficient to develop a site-specific model for SRS. 

Because the SRS case exhibited a clearance pattern that fell between the Mound and LANL models, 

the LANL model should be applied to SRS evaluations. 

These site-specific dissolution models should be used in dose reconstructions for insoluble forms of 

238Pu at the above facilities as a third dissolution type for 238Pu in addition to the standard types M and 

S. The dissolution type that results in the highest dose to the organ of interest should be used for the 

final dose assignment. Other sites may have relatively small quantities of 238Pu that was intentionally 

purified and processed to make it insoluble. Incidents involving exposure to such sources should be 

evaluated on a case-by-case basis with the LANL model. The models are intended for use with 238Pu 

similar to that in heat sources (basically pure 238Pu by activity); they are not appropriate for 238Pu 

mixtures with 239Pu or other radionuclides. 

2.0 BACKGROUND

Workers who are exposed to 238Pu can exhibit a wide variety of urinary excretion patterns that are 

indicative of very different dissolution rates of plutonium in the lung. For example, Guilmette et al.

(1994) described the urinary excretion resulting from exposures to 238Pu at three different facilities, 

and the patterns were very different. Perhaps the most interesting excretion patterns were those 

observed after the acute exposures of seven workers to a 238Pu cermet at the LANL Wing-9 facility in 

1971 [Facility 1 in Guilmette et al. (1994)]. These workers exhibited non-monotonic urinary excretion 

patterns like that in Figure 2-1, which suggests that the 238Pu was very insoluble at the time it was 

inhaled and became more soluble over time. 

This behavior has not been observed with 239Pu and is linked to the fact that 238Pu has a specific 

activity about 270 times higher than that of 239Pu (Mewhinney and Diel 1983). The high specific 

activity of the 238Pu causes aggregate recoil of 238Pu particles and radiation damage to the structure of 

the material. This results in relatively insoluble compounds like 238Pu oxide being more soluble than 

239Pu oxide in aqueous environments like those in the human body.

The non-monotonic urinary excretion curves that result from inhalation intakes of insoluble 238Pu are 

of interest for dose reconstruction for two reasons. First, the urinary excretion rate can be relatively 

low immediately after the inhalation intake, right when it might be expected to be highest with types M 

or S plutonium. This can result in an unconfirmed intake if urine bioassay alone is used to confirm the 

intake and no additional urine samples are collected.
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 7 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

Figure 2-1. Non-monotonic plutonium-238 urinary excretion curve 

observed in a worker involved in the 1971 LANL Wing-9 Event

Second, for a positive urine result not associated with a known intake, current dose reconstruction 

practice is to apply the International Commission for Radiological Protection (ICRP) recommendation 

in Publication 78 of assigning the intake date to the midpoint between the positive result and the last 

less-than result (ICRP 1998). With type M and type S plutonium, the magnitude of an intake from a 

single urine sample therefore increases as the elapsed time between the assumed intake and the 

sample increases. There is a period during which this relationship is reversed for 238Pu: the intake 

from a single urine sample increases as the elapsed time between the intake and the sample 

decreases. 

The increasing solubility over time that is shown in Figure 2-1 can be modeled by making appropriate 

modifications to the parameters of the respiratory tract dissolution model. The use of such 

modifications is the approach recommended by the ICRP (2002, Section 5.5.2) and allows the 

modified models to be implemented in IMBA.

3.0 DISSOLUTION MODELS

The standard dissolution model in ICRP Publication 66 (ICRP 1994) is shown below in Figure 3-1. 

This model describes the rate at which particles in the respiratory tract dissolve. The parameters in 

the model are the rate constants sp, spt, and st, each having units of 1/day. The parameter fb is equal 

to 0 by default, which has the effect of deleting the Bound Material compartment from the model.
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 8 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

Figure 3-1. Standard form of the ICRP Publication 66 

dissolution model (ICRP 1994, p. 65). 

An alternate parameterization of the dissolution model is shown in Figure 3-2. This model has the 

parameters ss, sr, and fr. These two models are mathematically equivalent; that is, values for the 

parameters in the models can be selected so that identical rates of dissolution and absorption into the 

blood stream will result.

Figure 3-2. Alternate form of the ICRP Publication 66 

dissolution model (ICRP 2002, page 168).

The standard form of the model is used here in the statistical procedure where the parameters are 

estimated from the data (see Attachments A and B). The alternate form of the model is useful for 

incorporating in vitro dissolution data (Ansoborlo et al. 1999) into a dose assessment, and is 

mentioned here because IMBA stores the alternate dissolution model parameters and converts the 

data to the standard form parameters as needed. This makes it advantageous to enter the alternate 

form parameters into IMBA. The parameters of the alternate form model can be calculated from the 

parameters of the standard form model using Equations 3-1 to 3-3 below.

r pt p ss s = + (3-1)

s t s s = (3-2)
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 9 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

t p

r

t pt p

s s

f

ss s

− = − − (3-3) 

Appendix A provides a discussion of the development of site-specific dissolution models for Mound 

and LANL. At these sites the appropriate model (see Table 3-1) is automatically used as a third 

dissolution type in addition to Type M and S for dose reconstructions. Other sites may have relatively 

small quantities of 238Pu that was intentionally purified and processed to make it insoluble. Incidents 

involving exposure to such sources should be evaluated on a case-by-case basis with the LANL 

model. The models in this report should not be applied to 238Pu that is a minor contaminant in other 

materials or to 238Pu that is known to be in a soluble form (e.g., as a nitrate solution).

The parameters for the alternate form models for LANL and Mound are given in Table 3-1. 

Table 3-1. Parameters of the Alternate Dissolution Model. The LANL 

model is used at LANL, NUMEC, SRS and any other site with the potential 

for exposure to insoluble forms of 238Pu. 

The general steps to enter the dissolution model into IMBA are:

• Select 238Pu as indicator radionuclide.

• Select ICRP-68 S Type defaults.

• Select “Absorption” button.

• Select “Alternative Representation” tab.

• Select “User Defined” button.

• Enter Table 3-1 values for fr, sr, ss, and f1. 

Site fr sr ss

Mound –8.46818E–02 2.91697E–02 2.64608E–03

LANL –1.56671E–01 1.89100E–03 2.57000E–04
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 10 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

An example of how to enter the parameters into IMBA is shown in Figure 3-3. Note that an f1 value of 

1 × 10-8 is used for both the LANL and Mound models.

Figure 3-3. Example of how the parameters for the alternate LANL 

dissolution model are entered into IMBA. 

4.0 ATTRIBUTIONS AND ANNOTATIONS

All information requiring identification was addressed via references integrated into the reference 

section of this document.
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 11 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

REFERENCES

Ansoborlo, E., M. H. Hengé-Napoli, V. Chazel, R. Gibert, and R. A. Guilmette, 1999, “Review and 

Critical Analysis of Available In Vitro Dissolution Tests,” Heath Physics, volume 77, number 6, 

pp. 638–645.

DOE (U.S. Department of Energy), 1993, Operable Unit 9, Site Scoping Report: Volume 7 - Waste 

Management, Final (Rev. 0), EG&G MOUND-29-01-01-07-07-9502080001, Albuquerque Field 

Office, Albuquerque, New Mexico, February. [SRDB Ref ID: 11877]

Guilmette, R. A., W. C. Griffith, and A. W. Hickman, 1994, “Intake Assessment for Workers Who Have 

Inhaled 238Pu Aerosols,” Radiation Protection Dosimetry, volume 53, numbers 1–4, pp. 127–

131. [SRDB Ref ID: 120904]

Hickman, A. W., W. C. Griffith, G. S. Roessler, and R. A. Guilmette, 1995, “Application of a Canine 

238Pu Biokinetics/Dosimetry Model to Human Bioassay Data,” Health Physics, volume 68, 

number 3, pp. 359–370.

ICRP (International Commission on Radiological Protection), 1979–1988, Limits for Intakes of 

Radionuclides by Workers, Publication 30, Parts 1–4 and Supplements, Pergamon Press, 

Oxford, England. [SRDB Ref ID: 22733]

ICRP (International Commission for Radiological Protection), 1994, Human Respiratory Tract Model 

for Radiological Protection, Publication 66, Pergamon Press, Oxford, England. [SRDB Ref ID: 

22732]

ICRP (International Commission for Radiological Protection), 1998, Individual Monitoring for Internal 

Exposure of Workers, Publication 78, Pergamon Press, Oxford, England. [SRDB Ref ID: 

36902]

ICRP (International Commission on Radiological Protection), 2002, “Supporting Guidance 3: Guide 

for the Application of the ICRP Human Respiratory Tract Model,” Annals of the ICRP, 

volume 32, numbers 1–2.

James, A. C., R. E. Filipy, J. J. Russell, and J. F. McInroy, 2003, “USTUR Case 0259 Whole Body 

Donation: A Comprehensive Test of the Current ICRP Models for the Behavior of Inhaled 

238PuO2 Ceramic Particles,” Health Physics, volume 84, number 1, pp. 2–33. [SRDB Ref ID: 

77731]

King, W. C., compiler, 1995, Mound Site Radionuclides by Location, Draft, Mound Laboratory, 

Miamisburg, Ohio, April 10. [SRDB Ref ID: 3234]

LANL (Los Alamos National Laboratory), 1995, “On the Front Lines, Plutonium Workers Past and 

Present Share Their Experiences,” Los Alamos Science, number 23, University of California, 

Los Alamos, New Mexico. [SRDB Ref ID: 43568]

Mewhinney, J. A., and J. H. Diel, 1983, “Retention of Inhaled 238PuO2 in Beagles: A Mechanistic 

Approach to Description,” Health Physics, volume 45, number 1, pp. 39–60.

Miller, G., W. C. Inkret, and H. F. Martz, 1999, “Internal Dosimetry Estimation Using Bayesian 

Methods,” Radiation Protection Dosimetry, volume 82, number 1, pp. 5–17.
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 12 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

Mulford, R. N. R., 1975, Degradation of Pioneer-Type Tantalum Alloy-PuO2 Heat Sources, LA-5932, 

University of California, Los Alamos Scientific Laboratory, Los Alamos, New Mexico, July. 

[SRDB Ref ID: 46721] 

Schulte, J. W., and R. N. R. Mulford, 1971, “Report on Contamination Release in Wing-9 of CMRBuilding on July 31, 1971,” memorandum to R. D. Baker, University of California, Los Alamos 

Scientific Laboratory, Los Alamos, New Mexico, August 6. [SRDB Ref ID: 76054]

Toy, H. L., 1972, “Request for Amendment to SNM-7,” letter to D. A. Nussbaumer (U.S. Atomic 

Energy Commission), Battelle Columbus Laboratories, Columbus, Ohio, March 16. [SRDB 

Ref ID: 122025, p. 60]

Woods, W. R. Jr., and W. E. Sheehan, 1971, “Evaluation of the PUQFUA Method of Calculating 

Systemic Burdens,” American Industrial Hygiene Association Journal, volume 32, number 1, 

pp. 58–63. [SRDB Ref ID: 46799]
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/14/2018 Page 13 of 52

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS

TABLE OF CONTENTS

SECTION TITLE PAGE

A.1 Los Alamos National Laboratory ............................................................................................ 14

A.2 Mound.................................................................................................................................... 19

A.3 Savannah River Site .............................................................................................................. 23

A.4 Nuclear Materials & Equipment Corporation........................................................................... 24

A.5 Summary of Modeling ............................................................................................................ 24

A.5.1 Site Plutonium-238 Models......................................................................................... 26

A.5.2 Alternate Dissolution Model ........................................................................................ 27

LIST OF TABLES

TABLE TITLE PAGE

A-1 Summary of dissolution parameters estimated from urinary excretion curves of selected 

LANL, Mound, and SRS workers who had intakes of plutonium-238...................................... 24

A-2 Summary of parameters for alternate and primary dissolution models ................................... 29

A-3 Summary of default dissolution model parameters for the default models .............................. 30

LIST OF FIGURES

FIGURES TITLE PAGE

A-1 Standard dissolution model from ICRP Publication 66 ........................................................... 17

A-2 Observed urinary excretion and fitted curve for LANL-8 ......................................................... 18

A-3 Plots of acute intake urinary excretion curves derived from eleven LANL cases 

compared to the urinary excretion curve for type S Pu-238.................................................... 19

A-4 Observed urinary excretion and fitted curve for Mound-13 ..................................................... 21

A-5 Plots of acute intake urinary excretion curves derived from nine Mound cases compared 

to the urinary excretion curve for type S Pu-238..................................................................... 22

A-6 Observed urinary excretion and fitted curve for SRS-24......................................................... 23

A-7 Plots of acute intake urinary excretion curves derived from LANL, Mound, and SRS 

cases (compared to the urinary excretion curve for types S and M Pu-238)........................... 26

A-8 Observed urinary excretion data with the USTUR fit and the LANL-8 fit................................. 28

A-9 Alternate form of ICRP 66 dissolution model.......................................................................... 28

A-10 Excretion curves for Mound-13, LANL-8, USTUR-23, SRS-24, and standard types M and 

S material...............................................................................................................................30
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 14 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

Dissolution models were developed by first identifying instances at LANL, Mound, and SRS where a

worker’s 238Pu urinary excretion exhibited the characteristic non-monotonic shape. After these cases 

were identified, the urinary excretion for each was modeled to estimate the intake and three 

dissolution parameters that provided the best fit to the data. The modeled cases are discussed in this 

attachment. 

A.1 LOS ALAMOS NATIONAL LABORATORY

A complete dataset of urine bioassay from 12,054 workers is available for LANL. These data were 

screened to identify workers who exhibited the characteristic non-monotonic 238Pu urinary excretion 

curve. The data for eleven workers was found to be suitable for modeling. Six of the workers were 

involved in the Wing-9 event on July 31, 1971, and the others had intakes from different events as 

described below.

LANL-3, -4,1 -5, -6, -8,2 -10 (Wing 9 Event)

These workers were involved with the well-known July 31, 1971, Wing-9 Event. This incident involved 

the airborne release of ground-up PuO2-Mo cermet disks from a radioisotopic thermoelectric 

generator (RTG). This was a major process upset. The incident report stated (Schulte and Mulford 

1971): 

• “The top two fuel discs were badly broken and a moderate amount of powdered fuel was 

present as a result of a vibration test which the heat source had undergone prior to shipment 

to LASL. The broken fuel was removed and the remaining intact discs were picked off with 

forceps.” 

• “During the removal, an estimated 30 grams of powdered fuel was shaken out of the capsule.” 

The data for LANL-8 was evaluated by the United States Transuranic and Uranium Registry (USTUR) 

and the results published in the Health Physics journal (James et al. 2003).

One of the primary industrial applications of 238Pu uses its high specific activity in an RTG to generate 

heat, which is in turn converted to electricity. These RTGs are used when a reliable, compact source 

of electricity is needed (e.g., deep space missions). One type of RTG was fabricated out of an 

extremely stable ceramic 238Pu (DOE 1993, p. 45) that was designed to survive reentry into the earth’s 

atmosphere from space. In 1971, seven3 workers in Wing-9 at LANL were working with such an RTG 

in a glovebox when they were inadvertently exposed to airborne material that was released through a 

hole in the glove. The material was described as a ceramic 238Pu with a molybdenum binder. There 

are few other details on the specifics of this event; the available information comes from brief 

descriptions in the open literature such as those by Miller et al. (1999), Guilmette et al. (1994), and 

Hickman et al. (1995).

 

1 In USTUR, case number is not known.

2 In USTUR, case number 0259.

3 The seventh worker could not be identified so is not included in the modeling. 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 15 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

Discussions with workers (published in 1995) who were involved in the event indicate that they were 

disassembling Systems for Nuclear Auxiliary Power (SNAP)-19 RTGs, which were used on the 

Pioneer deep space probes and the Transit navigation satellites (LANL 1995, pp. 15, 23). SNAP-19s 

were constructed from 238Pu cermet (DOE 1993, p. 40). A “cermet” is a composite of a metal and a 

ceramic, which are molybdenum and high-fired plutonium oxide, respectively, in this case. A cermet 

is produced by coating high-fired plutonium oxide with molybdenum and then heating the mixture 

under extreme pressure. The cermet is technically the chunk of material, not the ingredients that go 

into it. This means that to be exposed to a plutonium-bearing cermet, there must be a mechanism 

that generates a respirable airborne aerosol from the chunk of material.

The principal investigator for the Wing-9 event wrote a report in 1975 that discussed the results of 

studies on the degradation of the capsule that was used to keep the plutonium from dispersing as a 

result of a launch accident (Mulford 1975). The RTG that was the source of the contamination that 

night was designated TF-1, and it had been subjected to a fairly violent vibration test meant to 

reproduce launch conditions and then destructively analyzed (cut open) (Mulford 1975). Some 

contamination was always produced in a test like this and, if the cermet disks did not fit snugly in the 

outer capsule, a relatively large amount of respirable cermet aerosol could be produced. It appears 

that TF-1 was subjected to a vibration test that created powdered cermet of respirable size in the 

RTG. The RTG was cut open, and it released the cermet powder into the hot cell. Because of over 

pressurization in the containment (the operation had to be performed in an inert atmosphere) and a 

leak in a manipulator boot, the respirable aerosol was released into the cold area where the seven 

workers were exposed.

Intakes incurred by LANL-1, -2,4 -7, -9, and -11 were not associated with the Wing-9 event. Dosimetry 

records for these workers [who are not in the NIOSH-Division of Compensation and Analysis Claims 

Tracking System (NOCTS)] were obtained from LANL and reviewed to determine the most probable 

dates of the intakes. In the cases where there were no identifiable intakes, the dates of the intakes 

were selected by trial and error to obtain reasonable fits to the bioassay data. The findings are 

summarized below.

LANL-1 

[job title/location redacted]. No 238Pu incident reports.

• [month/day redacted], 1974: Plutonium-239/Americium-241 [exposure scenario redacted]. 

• [month/day redacted], 1980: Plutonium-239 [exposure scenario redacted]. Letter from LANL 

internal dosimetrist on [month/day redacted], 1981, states, “The increase in Mr. [name 

redacted] body burden is not due to this [exposure scenario redacted], but believed due to a 

Pu-238 [exposure scenario redacted] exposure on [month/day redacted],1975 which has 

increased steadily since this date.” 

• PUQFUA5 , the internal dose software used at the time, also indicates [exposure scenario 

redacted] on [month/day redacted], 1975.

 

4 In USTUR, case number is not known.

5 Stands for “plutonium body burden (Q) from urine analysis.”
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 16 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A

DEVELOPMENT OF DISSOLUTION MODELS (continued) 

• [record type redacted] on [month/day redacted], 1982 says:

– Exposed to plutonium continuously since 1946. 

– [exposure scenario redacted] in 1975 (did not find incident report for this). 

– Contaminated [exposure scenario redacted] in 1974 and [month redacted] 1980. 

– As of [month/day redacted], 1981, had body burden of 27.6 nCi of 238Pu and 25.9 nCi 

of 239Pu. Taken off plutonium work at that time.

• The worker was assumed to have had an intake on [month/day redacted], 1975, based on 

bioassay data.

LANL-2 

[job title/location redacted]. Removed from radiological work in 1974 because plutonium body burden 

reached 40 nCi. A number of [redacted] make reference to this worker reaching the limit in the early 

1970s, but there are no incident reports. In determining the most likely intake date, there are what 

appear to be alpha air monitoring records for 1971. The result from [month/day redacted], 1971, is 

larger than the rest. The maximum is 59 dpm/m3 with an average of 11. The rest of the days are 

primarily 0 to 5 dpm/m, with most only 1 or 2 dpm/m3

. The worker was assumed to have had an 

intake on [month/day redacted], 1971, based on his bioassay data and this information.

LANL-7 

[job title/location redacted]. Airborne alpha contamination records for [location redacted] (end in 

1964). No incident mentioned. The worker was assumed to have had an intake on [month/day 

redacted], 1971, based on his bioassay data.

LANL-9 

[job title redacted] involved in plutonium analysis in [location redacted]. 

• [month/day redacted], 1963: [exposure scenario redacted] plutonium-contaminated [redacted]. 

• [month/day redacted], 1970: Lung count result of 2.0 ±0.6 nCi 238Pu reported on [month/day 

redacted], 1971, high [redacted] count. No indication of contaminant, bottom of report says, 

“no contamination found.” 

• [month/day redacted], 1971: Plutonium-239 [exposure scenario redacted]. [location 

redacted], anion separation of 239Pu. [redacted] count slightly above background, declared “no 

significant contamination” and sent back to work.

• [month/day redacted], 1973: [exposure scenario/location redacted]. No plutonium detected on 

[redacted] counter.

• [month/day redacted], 1984: Plutonium-238 [redacted] intake (in memorandum from LANL 

internal dosimetrist on January 2, 1986).

• [month/day redacted], 1988: [exposure scenario/location redacted]. Did not know how or 

where. [redacted] count negative although report says 239Pu. 

• [month/day redacted], 1990: [exposure scenario redacted]. No detectable activity on 

[redacted]. 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 17 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

The worker was assumed to have had an intake on [month/day redacted], 1984, based on his 

bioassay data and this information.

LANL-11

[job title/location redacted]

[month/day redacted], 1980: Plutonium-238 intake – packaging waste for disposal and plastic bag

ruptured, no respiratory protection. No information about location or other details of incident – 

memorandum is from LANL internal dosimetrist 1.5 years ([month/day redacted], 1982) after intake, 

discussing body burden. The worker was assumed to have had an intake on [month/day redacted], 

1980, based on his bioassay data and this information.

The urine bioassay data for the eleven LANL workers were modeled to estimate for each worker the 

intake and the three parameters sp, spt, and st for the ICRP Publication 66 dissolution model (see 

Figure A-1). All other parameters of the respiratory tract and plutonium systemic models were held 

constant for all workers. 

Figure A-1. Standard dissolution model from ICRP 

Publication 66 (p. 65) 

For example, the observed excretion and curve of best fit for LANL-8 is shown in Figure A-2. The 

four parameter estimates are given on the plot. The intake is in picocuries, and the dissolution 

parameters are in units of 1/day. Similar plots for all eleven LANL cases are provided in 

Attachment B. 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 18 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

Figure A-2. Observed urinary excretion and fitted 

curve for LANL-8 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 19 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

Figure A-3 shows plots of acute intake urinary excretion curves from eleven LANL cases (red colored 

lines) in comparison with the urinary excretion curve for type S 238Pu (blue line). The case numbers 

are located at the maxima of the curves. The curve in black is for USTUR Case 0259. The estimates 

of the dissolution parameters are shown in Table A-2 (Section A.5.2 below). 

 Figure A-3. Plots of acute intake urinary excretion curves derived from 

 eleven LANL cases compared to the urinary excretion curve for type S Pu-238

A.2 MOUND

A complete dataset of urine bioassay from 2,082 workers is available for Mound. These data were 

screened to identify workers who exhibited the characteristic non-monotonic 238Pu urinary excretion 

curve. The data for the following nine workers was found to be suitable for modeling. 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 20 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

Mound-17 and -18 

On [month/day redacted], 1964, an accidental release of radioactive material occurred during a filter 

change in Room 35 of the Special Metallurgical Building (MORE6 Incident [number redacted]). The 

nature of material was not specified, but SM-35 is known to have handled 238Pu metal during this 

period (King 1995, p. 53). Plutonium-238 microspheres were not introduced into SM-35 until 1965, 

but there could have been some overlap (i.e., it is conceivable they were present). The intakes for 

these workers are assumed to have occurred on [month/day redacted], 1964.

Mound-13, -14, -15, -16, and -20

An accident occurred on July 6, 1960, as discussed by Woods and Sheehan (1971), during the 

purging operation of the inert atmosphere dry box in Room R-120 (MORE Incident #518). The 

released material was reported to be primarily insoluble plutonium dioxide, which is consistent with 

King (1995, p. 40) where it is stated that very fine 238Pu oxide powders were handled during this 

period. The intakes for these workers are assumed to have occurred on July 6, 1960.

Mound-12

The worker was assumed to have had an intake on [month/day redacted], 1962, based on his 

bioassay data. He was associated with Incident [number redacted] in [location redacted] on 

[month/day redacted], 1962, and Incident [number redacted] in [location redacted] on [month/day 

redacted], 1962 (MORE Incidents [numbers redacted]). The incident reports have not been found. 

Mound-19 

An intake by this worker on or near [month/day redacted], 1965, does not indicate it was from any of 

the incidents in the Mound incident database or with any incidents mentioned by King (1995). The 

date of the intake ([month/day redacted]/1965) was selected by trial and error to obtain a reasonable 

fit to the bioassay data. It could be reasonably argued that the observed data could be fit equally well 

using a standard dissolution model (i.e., it is not non-monotonic). 

The urine bioassay data for the nine Mound workers were modeled to estimate for each worker the 

intake and three parameters (sp, spt, and st) for the ICRP Publication 66 dissolution model. All other 

parameters of the respiratory tract and plutonium systemic models were held constant for all workers. 

For example, the observed excretion and curve of best fit for Mound-13 is shown below in Figure A-4. 

The four parameter estimates are given on the plot. The intake is in picocuries, and the dissolution 

parameters are in units of 1/day. Similar plots for all nine Mound cases are provided in Attachment B. 

Plots of the fitted excretion curves only (no observed data) for all nine Mound cases are shown in 

Figure A-5, and the estimates of the intakes and dissolution parameters are given in Table A-1. 

Figure A-5 illustrates the plots of acute intake urinary excretion curves from 9 Mound cases (gold 

colored lines) in comparison with the urinary excretion curve for type S 238Pu (blue line). The case 

numbers are located at the maxima of the curves.

 

6 Mound Occupational Radiation Exposure.
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 21 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

From Figure A-5, it is clear that most of the Mound cases represent a fairly tight band of curves. Two 

cases (Mound-12 and Mound-19) fall somewhat outside that band for part of the time frame. In both 

cases, a clear date of an acute intake was not established making developing parameters from these 

two cases less accurate. Mound-12 appeared to be involved in 2 different incidents raising the 

possibility of two separate intakes or at least putting the date of the intake in question. Likewise, the 

date of the intake for Mound-19 is in question since there was no documented incident and the date 

was determined through trial and error to fit the bioassay data. With the remaining cases following 

fairly similar curves, Mound-13 was chosen as being representative of the curves.

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

Figure A-4. Observed urinary excretion and fitted curve 

for Mound-13
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 22 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A

DEVELOPMENT OF DISSOLUTION MODELS (continued) 

 Figure A-5. Plots of acute intake urinary excretion curves derived from nine 

 Mound cases compared to the urinary excretion curve for type S Pu-238 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 23 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

A.3 SAVANNAH RIVER SITE

A complete bioassay dataset is not available for SRS, but all known incidents that resulted in doses in 

excess of 10 mrem committed effective dose have been evaluated (there are over 1,000 cases in the 

SRS Internal Dosimetry Registry). In thirty-two 238Pu intake cases, nonstandard respiratory tract 

parameters were used. A possible motivation for the use of nonstandard parameters would be to 

model non-monotonic urinary excretion patterns. Of the thirty-two cases of interest, six were modeled 

with ICRP Publication 30 (ICRP 1979–1988) respiratory tract model parameters that are suggestive of 

non-monotonic urinary excretion. Two of these cases are claimants and have data in NOCTS. The 

data for the other four workers who are not in NOCTS was obtained from the site. Only one of the six 

cases (SRS-24) was found to be suitable for modeling. The data for this case is included in this report 

only to show how it compares to the Mound and LANL cases. 

SRS-24

SRS-24 was [job title redacted] who [job duties and location redacted]. A routine urine sample 

collected in July 1981 contained 238Pu. Follow-up urine samples confirmed the intake. The time and 

cause of the intake were never identified, so the date of the intake ([month/day redacted], 1981) was 

selected by trial and error to obtain a reasonable fit to the bioassay data. 

The excretion curve for SRS-24 is shown in Figure A-6. The four parameter estimates are given on 

the plot. The intake is in picocuries, and the dissolution parameters are in units of 1/day. Estimates 

of the intake and dissolution parameters are given in Table A-1. 

Figure A-6. Observed urinary excretion and fitted 

curve for SRS-24 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 24 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A

DEVELOPMENT OF DISSOLUTION MODELS (continued) 

The other five cases were unsuitable as a result of one or more of the following reasons:

• The urinary excretion curve did not have the characteristic non-monotonic shape, or

• There were multiple intakes over time made it difficult to determine the shape of the excretion 

curve, or

• The worker received chelation therapy7, which perturbed the urinary excretion curve and 

confounded the effect of the non-monotonicity.

A.4 NUCLEAR MATERIALS & EQUIPMENT CORPORATION 

The bioassay data for twenty-two workers with data in NOCTS was reviewed and there was no 

indication of the characteristic non-monotonic urinary excretion curves. Data for non-claimants is not 

available. 

A.5 SUMMARY OF MODELING

A summary of the dissolution model parameters that were developed for each of the cases evaluated 

is provided in Table 1.

Table A-1. Summary of dissolution parameters estimated from urinary excretion curves of selected 

LANL, Mound, and SRS workers who had intakes of plutonium-238 (The parameters for standard 

Type S plutonium (S-21) and standard Type M plutonium (M-22) are also given). . 

 

7 A medical treatment with a drug that accelerates the excretion of plutonium from the body.
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 25 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

Table A-1 

ID Intake Date sp spt st

Intake

(pCi)

LANL-1 redacted/1975 1.887300E-05 7.400530E-03 4.514120E-04 1.500E+06

LANL-2 redacted/1971 1.350930E-04 3.031210E-03 1.280600E-03 9.000E+05

LANL-3 7/31/1971 1.999990E-06 6.100940E-04 1.894480E-03 4.129E+06

LANL-4 7/31/1971 8.685190E-06 6.030760E-03 3.419830E-04 9.019E+05

LANL-5 7/31/1971 7.000000E-06 8.201560E-03 1.676990E-04 2.533E+06

LANL-6 7/31/1971 1.000480E-06 6.745640E-03 1.571170E-04 1.200E+07

LANL-7 redacted/1971 1.000000E-06 6.021410E-04 6.030790E-04 1.650E+06

LANL-8 7/31/1971 3.857000E-05 8.565980E-04 3.071150E-04 1.500E+06

LANL-9 redacted/1984 1.909670E-05 3.212580E-03 8.543790E-05 4.061E+06

LANL-10 7/31/1971 2.748230E-08 4.408360E-03 1.533060E-04 1.767E+07

LANL-11 redacted/1980 1.000140E-06 3.551040E-03 5.482940E-04 3.300E+05

Mound-12 redacted/1962 4.683910E-06 3.358400E-03 3.364130E-03 3.000E+05

Mound-13 7/6/1960 4.000110E-04 2.876970E-02 2.646080E-03 3.200E+05

Mound-14 7/6/1960 4.000000E-04 5.064180E-03 5.464210E-03 4.000E+05

Mound-15 7/6/1960 4.000250E-04 2.752940E-02 2.513110E-03 6.300E+05

Mound-16 7/6/1960 9.157790E-04 7.354530E-03 4.229350E-03 2.000E+06

Mound-17 redacted/1964 9.977020E-04 4.788140E-01 1.902260E-03 4.400E+05

Mound-18 redacted/1964 4.674000E-04 4.674180E-03 5.142860E-03 7.587E+05

Mound-19 redacted/1965 9.000000E-05 3.548300E-03 3.639710E-03 1.100E+05

Mound-20 7/6/1960 4.000040E-04 2.092390E-02 2.598020E-03 7.391E+05

S-21 N/A 1.000000E-01 1.000000E+02 1.000000E-04 1.00E+00

M-22 N/A 1.000000E+01 9.000000E+01 5.000000E-03 1.00E+00

USTUR-23 7/31/1971 1.000000E-06 1.890000E-03 2.570000E-04 1.510E+06

SRS-24 redacted/1981 2.000000E-06 1.362470E-03 1.364290E-03 1.320E+06

Acute intake urinary excretion curves for all 21 workers, standard types M and S material and USTUR 

0259 listed in Table A-1, are shown in Figure A-7. Note that in Tables A-1 and A-2, LANL-8 and 

USTUR-23 are the same person, with LANL-8 using the evaluation method in this TIB and USTUR-23 

being the published results for USTUR Case 0259.
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 26 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

 Figure A-7. Plots of acute intake urinary excretion curves derived from 

 LANL, Mound, and SRS cases (compared to the urinary excretion curve for

 types S and M Pu-238) 

Figure A-7 shows plots of acute intake urinary excretion curves derived from LANL cases (red lines), 

Mound cases (gold lines), the SRS case (green line), and USTUR case (black line) in comparison with 

the urinary excretion curve for types S and M 238Pu (blue lines). The case numbers are located at the 

maxima of the curves. 

A.5.1 SITE PLUTONIUM-238 MODELS

Parameters for site-specific dissolution models for a given site were chosen from the parameters 

observed in the workers at that site.
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 27 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

• The parameters for Mound-13 are considered to be representative of those observed for 

Mound cases and should be used as the defaults for Mound. 

• The parameters for USTUR Case 0259 (USTUR-23) are considered to be representative of 

those observed for LANL cases and should be used as the defaults for LANL. 

• The LANL default model is considered to be the most conservative of the models and should 

be used for NUMEC and any other site where a 238Pu dissolution model is needed but was not 

explicitly defined in the report. Given that there is only one case available for evaluation at 

SRS, a site-specific dissolution model could not be developed. Examination of Figure A-7 

indicates the clearance pattern of 238Pu falls somewhere between that of Mound and LANL. 

Thus, the LANL model should also be used for SRS cases.

The parameters that were reported by the USTUR are used instead of those calculated here for 

LANL-8 because the USTUR considered autopsy data in addition to the urinary excretion and 

because the analysis was presented in a peer-reviewed journal. In Figure A-8, the USTUR curve 

(blue dashed line) is shown in comparison with the LANL-8 curve (black line) along with the bootstrap 

95% confidence interval (grey shaded band) of the LANL-8 curve. This illustrates the degree of 

uncertainty associated with the fits to the excretion data and that the differences between different fits 

to the same data can be significant, especially in the early times after the intake when the excretion 

rate is low.

A.5.2 ALTERNATE DISSOLUTION MODEL

IMBA stores the dissolution parameters in the alternate form of the dissolution model in Figure A-9 

and converts these parameters to the primary form of the model in Figure A-1 using the following 

equations:

r pt p ss s = + (A-1)

s t s s = (A-2)

 t p

r

t pt p

s s

f

ss s

− = − − (A-3)
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 28 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

Figure A-8. Observed urinary excretion data with the USTUR fit and the LANL-8 fit

Figure A-9. Alternate form of ICRP 66 dissolution 

model (ICRP 2002, page 168) 

The parameters for the default dissolution models are shown in Table A-2, and the fitted curves are 

shown in Figure A-10.
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 29 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

A summary of the site-specific dissolution model parameters developed using the available case data 

is given in A-2.

Table A-2. Summary of parameters for alternate and primary dissolution models

ID sp spt st sr ss fr

LANL-8 3.85700E-05 8.56598E-04 3.07115E-04 8.95168E-04 3.07115E-04 -4.56668E-01

Mound-13 4.00011E-04 2.87697E-02 2.64608E-03 2.91697E-02 2.64608E-03 -8.46818E-02

S-21 1.00000E-01 1.00000E+02 1.00000E-04 1.00100E+02 1.00000E-04 9.98003E-04

M-22 1.00000E+01 9.00000E+01 5.00000E-03 1.00000E+02 5.00000E-03 9.99550E-02

USTUR-23 1.00000E-06 1.89000E-03 2.57000E-04 1.89100E-03 2.57000E-04 -1.56671E-01

SRS-24 2.00000E-06 1.36247E-03 1.36429E-03 1.36447E-03 1.36429E-03 -7.56828E+03

 Figure A-10. Excretion curves for Mound-13, LANL-8, USTUR-23, 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 30 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT A 

DEVELOPMENT OF DISSOLUTION MODELS (continued)

 SRS-24, and standard types M and S material.8 

 Table A-3. Summary of default dissolution model parameters for

 the default models 

Site sr ss fr

Mound 2.91697E-02 2.64608E-03 –8.46818E-02

LANL 1.89100E-03 2.57000E-04 –1.56671E-01

 

8 The excretion curve for SRS is provided for comparison proposes only. As indicated above, the LANL model will be used 

as the default for SRS cases.
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 31 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS 

LIST OF FIGURES

FIGURES TITLE PAGE

B-1 Urinary excretion and fitted model for LANL-1 ........................................................................ 32

B-2 Urinary excretion and fitted model for LANL-2 ........................................................................ 33

B-3 Urinary excretion and fitted model for LANL-3 ........................................................................ 34

B-4 Urinary excretion and fitted model for LANL-4 ........................................................................ 35

B-5 Urinary excretion and fitted model for LANL-5 ........................................................................ 36

B-6 Urinary excretion and fitted model for LANL-6 ........................................................................ 37

B-7 Urinary excretion and fitted model for LANL-7 ........................................................................ 38

B-8 Urinary excretion and fitted model for LANL-8 ........................................................................ 39

B-9 Urinary excretion and fitted model for LANL-9 ........................................................................ 40

B-10 Urinary excretion and fitted model for LANL-10...................................................................... 41

B-11 Urinary excretion and fitted model for LANL-11...................................................................... 42

B-12 Urinary excretion and fitted model for Mound-12.................................................................... 43

B-13 Urinary excretion and fitted model for Mound-13.................................................................... 44

B-14 Urinary excretion and fitted model for Mound-14.................................................................... 45

B-15 Urinary excretion and fitted model for Mound-15.................................................................... 46

B-16 Urinary excretion and fitted model for Mound-16.................................................................... 47

B-17 Urinary excretion and fitted model for Mound-17.................................................................... 48

B-18 Urinary excretion and fitted model for Mound-18.................................................................... 49

B-19 Urinary excretion and fitted model for Mound-19.................................................................... 50

B-20 Urinary excretion and fitted model for Mound-20.................................................................... 51
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 32 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

The plots of the observed urinary excretion and fitted model are shown on log-log scale. The four 

parameter estimates are given on each plot along with the case identifier and date of intake. The R 

program file that was used to fit the data and create the plots for each case has the same name as 

the worker identifiers. For example, the fit and plot for LANL-1 were generated with the R file 

LANL-1.R. 

Figure B-1. Urinary excretion and fitted model for LANL-1 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 33 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-2. Urinary excretion and fitted model for LANL-2 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 34 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-3. Urinary excretion and fitted model for LANL-3 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 35 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-4. Urinary excretion and fitted model for LANL-4 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 36 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-5. Urinary excretion and fitted model for LANL-5 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 37 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-6. Urinary excretion and fitted model for LANL-6 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 38 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-7. Urinary excretion and fitted model for LANL-7 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 39 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-8. Urinary excretion and fitted model for LANL-8 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 40 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-9. Urinary excretion and fitted model for LANL-9 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 41 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-10. Urinary excretion and fitted model for LANL-10
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 42 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-11. Urinary excretion and fitted model for LANL-11. 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 43 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-12. Urinary excretion and fitted model for Mound-12. 
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 44 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-13. Urinary excretion and fitted model for Mound-13
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 45 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-14. Urinary excretion and fitted model for Mound-14
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 46 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-15. Urinary excretion and fitted model for Mound-15
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 47 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-16. Urinary excretion and fitted model for Mound-16
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 48 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-17. Urinary excretion and fitted model for Mound-17
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 49 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-18. Urinary excretion and fitted model for Mound-18
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 50 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-19. Urinary excretion and fitted model for Mound-19
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 51 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-20. Urinary excretion and fitted model for Mound-20
Document No. DCAS-RPT-005 Revision No. 01 Effective Date: 08/17/2018 Page 52 of 52

 

NOTICE: This report has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 USC §552a and has been cleared for distribution. 

ATTACHMENT B

FITS TO EXCRETION DATA FOR ALL WORKERS (continued)

Figure B-21. Urinary excretion and fitted model for SRS-24